Active, not recruitingPhase 2NCT06098313

HCT With PTCy in Higher-risk MDS

Studying Juvenile myelomonocytic leukemia

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Asan Medical Center
Intervention: Cyclophosphamide(drug)
Enrollment: 113 target
Eligibility: 15-75 years · All sexes
Timeline: 2020 – 2027

Study locations (1)

Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06098313 on ClinicalTrials.gov

Other trials for Juvenile myelomonocytic leukemia

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE2NCT03190915
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
National Cancer Institute (NCI)

See all trials for Juvenile myelomonocytic leukemia →

← Back to all trials